A Clinical Study on the Effect of Discontinuing Alendronate in Postmenopausal Women With Osteoporosis After a Treatment Period Without Fractures

Abroad (travel likely)RecruitingPHASE4

Conditions

Osteoporosis in Post-menopausal Women

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Aalborg University Hospital, Aalborg, Denmark
Contact: Study coordinator (Peter Vestergaard) · p.vestergaard@rn.dk · +4597660000
Bispebjerg Hospital, Copenhagen, Denmark
Contact: Study coordinator (Pia Eiken) · pia.eiken.01@regionh.dk · +4525889530
Esbjerg Og Grindsted Sygehus, Esbjerg, Denmark
Contact: Study coordinator (Jeppe Gram) · svs-forskning@rsyd.dk · +4521338706
Copenhagen University Hospital (Herlev), Herlev, Denmark
Contact: Study coordinator (Jakob Praest Holm) · jakob.praest.holm.01@regionh.dk · +4538683868
Nordsjaellands Hospital (Hillerød), Hillerød, Denmark
Contact: Study coordinator (Louise Tjelum) · louise.tjelum@regionh.dk · +4520485162
Hvidovre Hospital, Hvidovre, Denmark
Contact: Study coordinator (Jens-Erik Bech Jensen) · jens-erik.beck-jensen@regionh.dk · +4540427592
Odense University Hospital, Odense, Denmark
Contact: Study coordinator (Pernille Hermann, MD, PhD.) · pernille.hermann@rsyd.dk · +4523602366
Freja Gram, MD (Sub-investigator)
Lars Folkestad, MD, PhD (Sub-investigator)

Study leads

Pernille Hermann, MD, PhD.
Principal Investigator
Odense Universitetshospital / Odense University Hospital

View source on ClinicalTrials.gov